• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review - Product Image

Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review

  • Published: May 2013
  • Region: Global
  • 32 pages
  • GlobalData

FEATURED COMPANIES

  • Arthrex, Inc.
  • ArthroCare Corporation
  • OLYMPUS CORPORATION
  • WEIFA AS
  • MORE

Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list READ MORE >

List of Tables
List of Figures
Section 1 - About the Company
Navamedic ASA - Key Facts
Navamedic ASA - Key Employees
Navamedic ASA - Key Employee Biographies
Navamedic ASA - Major Products and Services
Navamedic ASA - History
Navamedic ASA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Navamedic ASA - Business Description
Navamedic ASA - Corporate Strategy
Navamedic ASA - SWOT Analysis
SWOT Analysis - Overview
Navamedic ASA - Strengths
Strength - Wide Marketing Presence
Strength - Supporting Subsidiary Operations
Navamedic ASA - Weaknesses
Weakness - Operational Inefficiency
Navamedic ASA - Opportunities
Opportunity - Product Portfolio Expansion Focus
Opportunity - Emerging Markets
Opportunity - Strategic Agreements and Collaborations
Navamedic ASA - Threats
Threat - Competitive Pressures
Threat - Product Liability Claims
Threat - Stringent Government Regulations
Navamedic ASA - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Navamedic ASA, Recent Deals Summary
Section 5 – Company’s Recent Developments
Navamedic ASA, Recent Developments
Feb 08, 2013: Navamedic Launches New Generic Drug
Feb 01, 2013: Navamedic Reorganizes Business Area Structure
Jan 15, 2013: Navamedic Launches Four Branded Generics In Dutch And Belgian Markets
Aug 23, 2012: Navamedic Reports Q2 2012 Results
Jun 05, 2012: Navamedic Subsidiary Signs Distribution Agreement With Vitaflo International
May 03, 2012: Navamedic Reports Q1 2012 Results
Feb 09, 2012: Navamedic Reports Q4 2011 Results
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
Navamedic ASA, Key Facts
Navamedic ASA, Key Employees
Navamedic ASA, Key Employee Biographies
Navamedic ASA, Major Products and Services
Navamedic ASA, History
Navamedic ASA, Subsidiaries
Navamedic ASA, Key Competitors
Navamedic ASA, Ratios based on current share price
Navamedic ASA, Annual Ratios
Navamedic ASA, Interim Ratios
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Navamedic ASA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Navamedic ASA, Performance Chart (2007 - 2011)
Navamedic ASA, Ratio Charts
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Navamedic ASA, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013

OLYMPUS CORPORATION
Arthrex, Inc.
ArthroCare Corporation
WEIFA AS
Nycomed International Management GmbH

Note: Product cover images may vary from those shown

RELATED PRODUCTS